These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 14557204

  • 1. Chemoreduction for retinoblastoma.
    Moll AC, Imhof SM, Schouten-van Meeteren AY, Boers M, van Leeuwen F, Hofman P.
    Arch Ophthalmol; 2003 Oct; 121(10):1513. PubMed ID: 14557204
    [No Abstract] [Full Text] [Related]

  • 2. Regarding chemoreduction for retinoblastoma and intracranial neoplasms.
    Meadows AT, Shields CL.
    Arch Ophthalmol; 2004 Oct; 122(10):1570-1; author reply 1571. PubMed ID: 15477483
    [No Abstract] [Full Text] [Related]

  • 3. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).
    Shields CL, Meadows AT, Shields JA, Carvalho C, Smith AF.
    Arch Ophthalmol; 2001 Sep; 119(9):1269-72. PubMed ID: 11545631
    [Abstract] [Full Text] [Related]

  • 4. Chemoreduction for retinoblastoma may prevent trilateral retinoblastoma.
    Shields CL, Shields JA, Meadows AT.
    J Clin Oncol; 2000 Jan; 18(1):236-7. PubMed ID: 10623718
    [No Abstract] [Full Text] [Related]

  • 5. Multifaceted chemotherapy for trilateral retinoblastoma.
    Dimaras H, Héon E, Doyle J, Strahlendorf C, Paton KE, Halliday W, Babyn P, Gallie BL, Chan HS.
    Arch Ophthalmol; 2011 Mar; 129(3):362-5. PubMed ID: 21402997
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retinoblastoma: evidence for postenucleation adjuvant chemotherapy.
    Kim JW.
    Int Ophthalmol Clin; 2015 Mar; 55(1):77-96. PubMed ID: 25436495
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL, Shelil A, Cater J, Meadows AT, Shields JA.
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma.
    Shields CL, Sun H, Manquez ME, Leahey A, Meadows AT, Shields JA.
    Arch Ophthalmol; 2006 Aug; 124(8):1196-7. PubMed ID: 16908826
    [No Abstract] [Full Text] [Related]

  • 12. What is the best treatment for retinoblastoma?
    Harbour JW.
    Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
    Dunkel IJ, Jubran RF, Gururangan S, Chantada GL, Finlay JL, Goldman S, Khakoo Y, O'Brien JM, Orjuela M, Rodriguez-Galindo C, Souweidane MM, Abramson DH.
    Pediatr Blood Cancer; 2010 Mar; 54(3):384-7. PubMed ID: 19908299
    [Abstract] [Full Text] [Related]

  • 16. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.
    Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.